Volume 3, Issue 5: Cure of Hepatitis B: Is it Achievable?

e-Viral Hepatitis Review is a monthly CE series for nurses, nurse practitioners, and others involved in the care of patients with Hepatitis. It provides updates on the latest research, best practices, and issues currently under debate, as well as a concise review of relevant journal literature.

 

(Volume 3, Issue 5)

Target Audience

Nurses and health care professionals involved in the care of patients with Hepatitis.

Learning Objectives

After participating in this activity, the participant will demonstrate the ability to:      

  • Describe current evidence showing that achieving viral suppression can significantly improve fibrosis and decrease the incidence of hepatocellular carcinoma
  • Explain how HBsAg loss can be considered a serologic/virologic cure that allows treatment cessation
  • Describe how, despite HBsAg clearance, reactivation of HBV and/or development of hepatocellular carcinoma may occur
 
Additional information
Contact email: 
ijhn@jhmi.edu
Course summary
Available credit: 
  • 1.00 ANCC
Registration opens: 
12/31/2013
Registration closes: 
12/30/2015
Cost:
$0.00
Fabien Zoulim, MD, PhD
Professor, Head of INSERM Viral Hepatitis Laboratory
Medical School of Lyon, Lyon 1 University
Hepatology Department, Hospices Civils de Lyon
Lyon, France
 
Kerstin Hartig-Lavie, MD
Hepatology Department
Hospices Civils de Lyon
Lyon, France
 

 

Available Credit

  • 1.00 ANCC

Price

Cost:
$0.00
Please login or register to take this course.

Required Hardware/software

Make sure your Adobe flash is updated by clicking HERE.